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Biofilm eradication in
catheter-related infection
in dialysis patients
To the Editor: Lok and Mokrzycki1 have to be congratulated
for their excellent review article on the prevention and
management of catheter-related infection/bacteremia (CRB)
in hemodialysis (HD) patients. They discuss extensively the
pathogenesis of CRB and both the role of catheter coloniza-
tion and bioﬁlm production by microorganisms. Indeed,
bioﬁlm production prevents antibiotic penetration and action,
further sustaining release of microorganisms. The authors
also review different prophylactic antimicrobial locking
solutions, both antibiotic and non-antibiotic, of which some
have been shown to prevent or eradicate bioﬁlm formation.1
In peritoneal dialysis (PD) patients, bioﬁlm formation due
to coagulase-negative Staphylococcus (CoNS) has also been
associated with persisting asymptomatic peritonitis (deﬁned
as a peritonitis episode treated with vancomycin, with
signiﬁcant clinical improvement within 48 h and dialysate
clearing, but with persisting positive dialysate cultures).2 The
use of intraperitoneal urokinase (100,000 units), a plasmino-
gen activator, and oral rifampicin in addition to intravenous
vancomyin in these patients may lead to peritonitis resolution
with sterilization of the dialysate in up to 64% of the cases,
therefore avoiding catheter removal and interim hemo-
dialysis.2 High-dose urokinase probably allowed the
dissolution of bioﬁlm lining the PD catheter, permitting
thereafter a better action of rifampicin and vancomycin. Such
approach merits prospective testing in both HD and PD
patients with mild catheter-related infection, and probable
bioﬁlm formation, in relation to indolent microorganisms
such as CoNS.
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